MedTrace Logo

A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy

NCT00597181 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-09-17

No results posted yet for this study

Summary

The less invasive nature of the Ex-Press Mini shunt with mitomycin C induces less post-operative inflammation than trabeculectomy with mitomycin c.

Conditions

Interventions

PROCEDURE

Trabeculectomy with mitomycin c

mitomycin c 0.2 mg/cc for 2 minutes

PROCEDURE

Ex-Press mini shunt with mitomycin c

mitomycin c 0.2 mg/cc for 2 minutes

Sponsors & Collaborators

  • Optonol

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Principal Investigators

  • Louis B Cantor, MD · Indiana University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-01-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00597181 on ClinicalTrials.gov